# Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-evaluating-donor-eligibility-using-individual-risk-based-questions-to-reduce-the-risk-of-human-immunodeficiency-virus-transmission-by-blood-and-blood-products-guidance-for-industry/2aa5412b-2ce3-4c75-b71e-e133b6e6afe5

> FDA guidance document: Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products:  Guidance for Industry. Issue date: May 11, 2023. Get complete insights and analysis.

---

## Details

- Title: Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2023-05-11
- Last Changed: 2025-01-31
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2015-D-1211">FDA-2015-D-1211</a>

## Related Documents

- [Blood Pressure and Pulse Donor Eligibility Requirements – Compliance Policy:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/blood-pressure-and-pulse-donor-eligibility-requirements-compliance-policy-guidance-for-industry/615d0678-665d-430f-b65f-b6436cb2069f)
- [Long Term Follow-up After Administration of Human Gene Therapy Products:   Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/long-term-follow-up-after-administration-of-human-gene-therapy-products-guidance-for-industry/5f3e0db9-8c8a-45b5-864f-6250a3250b1b)
- [Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-nucleic-acid-tests-to-reduce-the-risk-of-transmission-of-hepatitis-b-virus-from-donors-of-human-cells-tissues-and-cellular-and-tissue-based-products-guidance-for-industry/ff060472-0a8c-471b-b947-33ce77342401)